phrykt

Exascale Labs Holdings Inc. (XLAB): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of XLAB were reported in the last 12 months. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No XLAB insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

XLAB short interest

708,675 XLAB shares are sold short. Over the last 5 reports the number of shares short went up 37%.

As of Oct 30, 2026, 708,675 XLAB shares were sold short, up 1706.5% from the report before. At the average daily volume of 30.23M shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short

708,675Aug 31Oct 30809,092

Days to cover

1.0Aug 31Oct 301.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026708,675–+1707%30.23M1.0
Oct 15, 202639,229–-10%1.52M1.0
Sep 30, 202643,764–-40%60,9561.0
Sep 15, 202673,108–-86%99,8561.0
Aug 31, 2026518,598––500,0751.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Exascale Labs company events

Exascale Labs filed 7 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership, listing). The latest was on Nov 9, 2026.

  1. Nov 9, 2026AgreementExascale Labs Holdings Inc. (Nasdaq: XLAB, XLABW), a Delaware corporation, countersigned proforma invoice No. 2026103003 issued and signed by Compal Electronics, Inc., a company organized under the laws of Taiwan, for the purchase by the Company of sixteen (16) Intel BHS 10U GPU servers with NVIDIA… Filing
  2. Oct 15, 2026AgreementExascale Labs Holdings Inc. (Nasdaq: XLAB, XLABW), a Delaware corporation, entered into a purchase and sale agreement dated as of October 8, 2026 with the buyer, Sunon Inc., a California corporation and a U.S. subsidiary of Sunonwealth Electric Machine Industry Co., Ltd. (TWSE: 2421), Kaohsiung… Filing
  3. Sep 30, 2026LeadershipGildas Bonnier ceased serving as the Interim Chief Financial Officer of Exascale Labs Holdings Inc. Filing
  4. Sep 28, 2026ResultsReleased financial results. Filing
  5. Sep 28, 2026DealAmended an earlier report. Of the Original Form 8-K to include (a) the audited consolidated financial statements of Exascale as of and for the years ended June 30, 2026 and 2025, (b) Management’s Discussion and Analysis of Financial Condition and Results of Operations of Exascale for the years ended June 30, 2026 and 2025… Filing
  6. Sep 8, 2026LeadershipExascale Labs Holdings Inc. appointed Gildas Bonnier as Interim Chief Financial Officer of the Company, effective as of September 4, 2026. Filing
  7. Sep 2, 2026ListingPrior to the consummation of the Business Combination, the BCAR Units, the BCAR Class A Ordinary Shares and the BCAR Warrants were listed on Nasdaq under the symbols “BCARU,” “BCAR” and “BCARW,” respectively. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Exascale Labs financials

Famous investors that hold XLAB

2 of the 50 well-known investors we track reported holding XLAB in their latest 13F filing. The largest position is Ken Griffin's, worth $75.5K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202640,811$75.5K0.0%New
Steve Cohen · Point72 Asset ManagementQ3 2026289,296$46.3K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named XLAB in the last 120 days.

FiledHolderFormStake
Oct 29, 2026Hack Seed Fund II LP13G5.9%
Oct 29, 2026Hack Seed Fund II LP13G5.9%
Oct 15, 2026ARC Group International Limited13G14.7%
Oct 15, 2026ARC Group International Limited13G14.7%

Questions about Exascale Labs Holdings Inc. (XLAB) stock

Are XLAB insiders buying or selling?

No XLAB insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in XLAB?

As of Oct 30, 2026, 708,675 XLAB shares were sold short, up 1706.5% from the report before. At the average daily volume of 30.23M shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold XLAB?

2 of the 50 well-known investors we track reported XLAB in their latest 13F filing, including Ken Griffin, Steve Cohen. The largest position is worth $75.5K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.